Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...
Jul 20, 2017
0
17